Form 4: Zoetis Inc. Executive Vice President Julie Fuller Reports Acquisition of Restricted Stock Units

Executive Vice President of Zoetis Inc., Julie Fuller, reports the acquisition of 2,324 restricted stock units (RSUs) on September 30, 2024, under the company's equity and incentive plan.

Summary

• On September 30, 2024, Julie Fuller, Executive Vice President of Zoetis Inc., acquired 2,324 restricted stock units (RSUs).
• These RSUs were granted under the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
• Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
• One-third of the RSUs will vest and be settled in shares on the first, second, and third anniversaries of the grant date, contingent upon continued service.
• The reporting person directly owns 2,324 derivative securities after the reported transaction.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices and aligns executive interests with shareholder value. There are no immediate negative implications.

Positives

• The grant of RSUs aligns the executive's interests with those of the shareholders, incentivizing continued service and performance.

Risks

• The vesting of the RSUs is contingent upon the reporting person's continued service, creating a potential risk if the executive leaves the company before the vesting dates.

Future Outlook

The executive will receive shares of Zoetis Inc. common stock as the RSUs vest over the next three years, contingent on continued service.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation practices, common in publicly traded companies to ensure transparency regarding insider transactions.

Comparison to Industry Standards

• Granting restricted stock units is a common practice among publicly traded companies to incentivize and retain key executives.
• Companies like Elanco Animal Health (ELAN) and Merck & Co. (MRK), which also operate in the animal health industry, use similar equity-based compensation plans.
• The vesting schedules, typically ranging from three to five years, are also standard in the industry.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it incentivizes executive performance and aligns interests.
• Employees may see this as a standard part of executive compensation.

Key Dates